Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fission yeast myosin-II isoforms assemble into contractile rings at distinct times during mitosis.

Current biology : CB·2001
Same author

Congenital diaphragmatic hernia: where are we and where do we go from here?

Seminars in perinatology·2001
Same author

Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic.

Journal of pediatric surgery·2001
Same author

A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates.

Molecular therapy : the journal of the American Society of Gene Therapy·2000
Same author

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Journal of virology·2000
Same author

Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.

Gene therapy·2000

Related Experiment Video

Updated: Jun 5, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Gene therapy of hypercholesterolemic disorders.

K F Kozarsky1, J M Wilson

  • 1Karen F. Kozarsky and James M. Wilson are at the Institute for Human Gene Therapy, the University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Molecular and Cellular Engineering, the University of Pennsylvania, Philadelphia, PA 19104, USA.; the Wistar Institute, Philadelphia, PA 19104, USA.

Trends in Cardiovascular Medicine
|January 15, 2011
PubMed
Summary

Gene therapy offers potential for treating genetic hypercholesterolemia by introducing normal genes. Studies in familial hypercholesterolemia and apolipoprotein E deficiency models show promise and limitations.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Hypercholesterolemia involves defective genes leading to high cholesterol levels.
  • Familial hypercholesterolemia (low density lipoprotein receptor deficiency) and apolipoprotein E deficiency are key genetic disorders.
  • Animal models are crucial for evaluating gene therapy efficacy.

Purpose of the Study:

  • To investigate the therapeutic potential of gene therapy for hypercholesterolemic disorders.
  • To highlight the current state, including benefits and drawbacks, of gene therapy in lipoprotein metabolism.

Main Methods:

  • Utilizing animal models for familial hypercholesterolemia (low density lipoprotein receptor deficiency).
  • Employing animal models for apolipoprotein E deficiency (type III hyperlipoproteinemia).
  • Analyzing gene therapy efficacy in these specific genetic models.

Main Results:

  • Demonstrated therapeutic potential of gene therapy in selected hypercholesterolemia models.
  • Identified drawbacks and limitations associated with current gene therapy approaches.
  • Provided insights into lipoprotein metabolism through these genetic paradigms.

Conclusions:

  • Gene therapy shows promise for treating genetic hypercholesterolemia.
  • Current gene therapy techniques have limitations that require further research.
  • Model systems are vital for advancing gene therapy for metabolic disorders.